Paper22101652
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
Cirri P and 1 other. Cancer Metastasis Rev, 2012. Cited by 420 papers, by iCite.
Cite this record
ConductScience Library. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Papers, record 22101652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22101652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblasts | Major topic |
| Neoplasms | Major topic |
| Disease Progression | |
| Epithelial-Mesenchymal Transition | |
| Humans | |
| Stromal Cells | |
| Tumor Microenvironment |
Source PubMed
Cited by280
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 420 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42554469 | Hippo Pathway Regulation and Microenvironmental Cues Governing Human MSC Transition to Cancer-Associated Fibroblasts. | J Cell Physiol | 2026 | https://conductscience.org/library/papers/42554469 | PubMed |
| 42517964 | Cancer-associated fibroblasts: The silent conductors of tumor evolution and therapy refractoriness. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42517964 | PubMed |
| 42353345 | From Chronic Inflammation to Malignancy: Molecular Mechanisms and Therapeutic Insights in Oral Carcinogenesis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353345 | PubMed |
| 42088621 | BDKRB1 Links Copy Number-Defined Genomic Instability to Inflammatory and Immunosuppressive Tumor Ecosystems in Ovarian Cancer: An Integrative Multiomics Analysis. | Int J Genomics | 2026 | https://conductscience.org/library/papers/42088621 | PubMed |
| 41799193 | Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer. | Theranostics | 2026 | https://conductscience.org/library/papers/41799193 | PubMed |
| 41423542 | Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/41423542 | PubMed |
| 41293172 | A mitochondrial lipid metabolism-related gene signature predicts prognosis and immune landscape in colorectal cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/41293172 | PubMed |
| 41284138 | Colorectal cancer cell-derived exosomes induce metabolic reprogramming of cancer-associated fibroblasts to promote colorectal cancer growth. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41284138 | PubMed |
| 41033664 | Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer. | Bioconjug Chem | 2025 | https://conductscience.org/library/papers/41033664 | PubMed |
| 40973793 | Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition. | Oncogene | 2025 | https://conductscience.org/library/papers/40973793 | PubMed |
| 40959429 | A mitochondrial ferroptosis-related gene signature predicts prognosis and immune landscape in colon cancer. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40959429 | PubMed |
| 40665579 | Cancer stem cells: Bridging microenvironmental interactions and clinical therapy. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40665579 | PubMed |
| 40591015 | FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in Adamantinomatous craniopharyngioma. | Pituitary | 2025 | https://conductscience.org/library/papers/40591015 | PubMed |
| 40558563 | Free Methylglyoxal and Lactate Produced and Released by Cultured Cancer and Non-Cancer Cells: Implications for Tumor Growth and Development. | Cells | 2025 | https://conductscience.org/library/papers/40558563 | PubMed |
| 40299639 | A Nexus of Biomolecular Complexities in Pituitary Neuroendocrine Tumors: Insights into Key Molecular Drivers. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299639 | PubMed |
| 40094065 | Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights. | APL Bioeng | 2025 | https://conductscience.org/library/papers/40094065 | PubMed |
| 39816375 | Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39816375 | PubMed |
| 39588377 | Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39588377 | PubMed |
| 39482912 | Molecular Targets and Nano-Technological Approaches in the Treatment of Hepatic Carcinoma. | Curr Cancer Drug Targets | 2025 | https://conductscience.org/library/papers/39482912 | PubMed |
| 39440039 | Different subpopulations of macrophages, neutrophils, mast cells, and fibroblasts are involved in the control of tumor angiogenesis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39440039 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22101652
GET https://conductscience.org/api/papers/v1/22101652/cited_by?page=2